Trade Replimune - REPL CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.07 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.02629% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.004068% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 10.5 |
| Open | 10.39 |
| 1-Year Change | -48.31% |
| Day's Range | 10.25 - 10.46 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Jul 25, 2024 | 10.45 | 0.23 | 2.25% | 10.22 | 10.90 | 10.04 |
| Jul 24, 2024 | 10.22 | 0.49 | 5.04% | 9.73 | 10.46 | 9.73 |
| Jul 23, 2024 | 10.01 | 0.38 | 3.95% | 9.63 | 10.15 | 9.51 |
| Jul 22, 2024 | 9.81 | -0.03 | -0.30% | 9.84 | 9.86 | 9.53 |
| Jul 19, 2024 | 9.85 | -0.13 | -1.30% | 9.98 | 10.13 | 9.73 |
| Jul 18, 2024 | 10.03 | -0.46 | -4.39% | 10.49 | 10.50 | 9.98 |
| Jul 17, 2024 | 10.61 | -0.25 | -2.30% | 10.86 | 11.04 | 10.34 |
| Jul 16, 2024 | 11.02 | 0.54 | 5.15% | 10.48 | 11.22 | 10.48 |
| Jul 15, 2024 | 10.78 | 0.57 | 5.58% | 10.21 | 10.86 | 10.00 |
| Jul 12, 2024 | 10.33 | 0.32 | 3.20% | 10.01 | 10.48 | 9.82 |
| Jul 11, 2024 | 9.90 | 1.39 | 16.33% | 8.51 | 10.00 | 8.51 |
| Jul 10, 2024 | 8.62 | -0.16 | -1.82% | 8.78 | 8.78 | 8.41 |
| Jul 9, 2024 | 8.76 | 0.51 | 6.18% | 8.25 | 8.85 | 8.15 |
| Jul 8, 2024 | 8.42 | 0.31 | 3.82% | 8.11 | 8.50 | 7.98 |
| Jul 5, 2024 | 8.07 | 0.04 | 0.50% | 8.03 | 8.09 | 7.84 |
| Jul 3, 2024 | 7.88 | -0.30 | -3.67% | 8.18 | 8.33 | 7.88 |
| Jul 2, 2024 | 8.34 | -0.95 | -10.23% | 9.29 | 9.29 | 8.15 |
| Jul 1, 2024 | 9.32 | 0.55 | 6.27% | 8.77 | 9.46 | 8.77 |
| Jun 28, 2024 | 8.95 | 0.43 | 5.05% | 8.52 | 8.96 | 8.31 |
| Jun 27, 2024 | 8.49 | -0.02 | -0.24% | 8.51 | 8.76 | 8.32 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Replimune Company profile
About Replimune Group Inc
Replimune Group, Inc. is a clinical-stage biotechnology company. The Company is engaged in the field of oncolytic immunotherapy to treat the cancer patients. The Company applies its Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The Company is focused on developing a pipeline of oncolytic immunotherapy product candidates to provide clinical benefits to cancer patients. Its product candidates include RP1 (vusolimogene oderparepvec), RP2, and RP3. The Company is focused on Phase 2 clinical trials with its lead product candidate, RP1, in approximately 240 patients with a range of solid tumors.
Financial summary
BRIEF: For the nine months ended 31 December 2021, Replimune Group Inc revenues was not reported. Net loss increased 45% to $86.3M. Higher net loss reflects Research and development increase of 41% to $49.7M (expense), Stock-based Compensation in SGA increase from $4.6M to $12M (expense), General and administrative increase of 38% to $16.1M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$1.34 to -$1.66.
| Industry: | Biotechnology & Medical Research (NEC) |
500 Unicorn Park Dr
WOBURN
MASSACHUSETTS 01801-3377
US
News
How to manage risk when trading
Learn what risk management is and find out how understanding about it could help you identify potential risks in your investment portfolio. Find out more.
06:57, 22 July 2024
ECB preview: lack of new data sees markets expecting a hold
Markets expect the ECB to keep rates unchanged in July but expectations for a September cut rise
13:13, 18 July 2024
What is an IPO and how does it work?
Learn about what an IPO is, why they are important, and how they work.
07:19, 10 July 2024
What are the biggest stock exchanges worldwide?
Discover the largest stock exchanges in the world by market capitalisation, including the Nasdaq Stock Market, the New York Stock Exchange and the London Stock Exchange.
12:44, 9 July 2024
Top ETFs
ETFs, or exchange-traded funds, offer traders a versatile gateway into the financial markets.
16:23, 8 July 2024
Lloyds forecast: will Lloyds share price return to £1? Third party data forecast
What’s next for Lloyds amid higher inflation and the start of a potential recessionary cycle in the UK?
14:00, 8 July 2024
RBNZ Preview: OCR expected to remain unchanged as central bank focuses on inflation
The Reserve Bank of New Zealand meets on Wednesday, July 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.
13:25, 8 July 2024People also watch
Still looking for a broker you can trust?
Join the 630,000+ traders worldwide that chose to trade with Capital.com